Biohal: New Blockchain Technology Finds Cancer And Determines Alzheimer’s (Asterisk)
A new company named Biohal from Malta has created the world’s first medical blockchain technology to determine if a patient has Alzheimer or Cancer. Cancer and Alzheimer’s are both relatively unknown diseases, particularly as to what causes them, also how to detect them. But with the breakthrough technology, doctors can detect cancer as early as stage 0, something that is unprecedented. Although current medical facilities can detect both diseases early on, they tend to cost an arm and a leg.
Early treatment is the key to saving patients from either of the unfortunate conditions. Due to new therapies, both Alzheimer and Cancer insurance in nearly all major countries are at a steady increase in cost. At the same time, coverage is covering less with treatment frequently considered to be inadequate for helping those in need. Poverty stricken people in many countries are particularly at risk, mostly from the so-called advanced treatments being non-effective or unavailable without the money to pay for it.
Biohal’s goal is to make detecting the diseases accessible to everyday people, not just the rich and wealthy. It’s proven that preventative measures tend to be the best when it comes to getting rid of cancer and Alzheimer. Cancer, for example, takes radiation to treat, which tends to be extremely hard on the body. As for Alzheimer's, treatment rarely has the desired effect people assume it does.
BIOHAL solves a plethora of medical issues that derail a patient’s life. On behalf of the scientists who deal with the terminal diseases and bringing a cure for it, we have launched BIOHAL. The life of the individuals and their families can live with a peace of mind knowing there is an accurate early detection test with preventive medicine from BIOHAL.” Yuki Hasegawa, Founder/CEO, BIOHAL.
The network works to detect either of the conditions deep inside the patient’s DNA. Other partnerships forming are used to guarantee tests are efficiently accurate, one connection is with PROTEO an innovator in the transporting serums or specimens for testing. To pay for the tests, patients will use PON coins, the company tokens that BIOHAL has developed to run the system. Coins can be used to pay for screening, tests, buy supplies, medical products or to sell and trade. The ICO for the company is about to start on September 18th, 2018 – with presales offering a bonus – it should go off with a bang, paving the way for a future of efficient testing for cancer and Alzheimer’s.
What do you think of the new blockchain testing platform? What other diseases would benefit from like technology? Leave your answers in the questions below.